Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid LeukemiaJohn C. Byrd, Peter Hillmen, Neil E. Kay et al.|New England Journal of Medicine|2014Cited by 1.6k
Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based studyAytug Kizilors, Hugues de Lavallade, Elena Crisà et al.|The Lancet Haematology|2019Cited by 56